Management of agitation in the intensive care unit

Clinics in Chest Medicine

Volumn 24, Issue 4, 2003, Pages 713-725

  Siegel, Mark D ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXMEDETOMIDINE; ERYTHROMYCIN; FENTANYL DERIVATIVE; FLUCONAZOLE; FLUMAZENIL; HALOPERIDOL; HYDROMORPHONE; LORAZEPAM; MIDAZOLAM; MORPHINE DERIVATIVE; NARCOTIC AGENT; NEUROLEPTIC AGENT; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT; SUFENTANIL;

ADRENAL INSUFFICIENCY; AGITATION; ANXIETY DISORDER; ARTIFICIAL VENTILATION; BEHAVIOR DISORDER; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; COGNITION; COST CONTROL; CRITICAL ILLNESS; DELIRIUM; DRUG WITHDRAWAL; DYSPHORIA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE UNIT; METABOLIC ACIDOSIS; NAUSEA; PANCREATITIS; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SURVIVAL; VOMITING;

EID: 0346993076     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(03)00104-7     Document Type: Review

References (110)

1. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. [erratum appears in Crit Care Med 2002;30(3):726] Crit Care Med 2002;30(1):119-41.
2. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. [erratum appears in Crit Care Med 2002;30(3):726] Crit Care Med 2002;30(1):119-41.
3. Fraser GL, Riker RR, Berthiaume DR, et al. A Prospective study of the incidence, severity, and therapeutics used for agitation in elderly versus younger critically ill patients. Chest 1998;26(1S):101A.
4. Fraser GL, Prato BS, Riker RR, et al. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy 2000;20(1): 75-82.
5. Hansen-Flaschen JH, Brazinsky S, Basile C, et al. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA 1991;266:2870-5.
6. Rhoney DH, Murry KR. National Survey of the Use of Sedating Drugs, Neuromuscular Blocking Agents, and Reversal Agents in the Intensive Care Unit. J Intensive Care Med 2003;18:139-45.
7. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients - reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003;289(22):2983-91.
8. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342(20):1471-7.
9. Kollef MH, Levy NT, Ahrens TS, et al. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114(2): 541-8.
10. Mascia MF, Koch M, Medicis JJ. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med 2000;28(7):2300-6.
11. Devlin JW, Holbrook AM, Fuller HD. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother 1997;31(6):689-95.
12. Sessler CN, Grap MJ, Brophy GM. Multidisciplinary management of sedation and analgesia in critical care. Sem Resp Crit Care Med 2001;22:211-26.
13. Hansen-Flaschen J. Improving patient tolerance of mechanical ventilation: challenges ahead. Crit Care Clin 1994;10:659-71.
14. Chevron V, Menard JF, Richard JC, et al. Unplanned extubation: risk factors of development and predictive criteria for reintubation. Crit Care Med 1998;26(6): 1049-53.
15. Boulain T. Unplanned extubations in the adult intensive care unit: a prospective multicenter study. Association des Reanimateurs du Centre-Ouest. Am J Respir Crit Care Med 1998;157(4 Pt 1):1131-7.
16. Dick C, Sassoon C. Patient-ventilator interactions. Clin Chest Med 1996;17:423-38.
17. Epstein SK. Optimizing patient-ventilator synchrony. Sem Resp Crit Care Med 2001;22:137-52.
18. Kallet RH, Alonso JA, Luce JM, et al. Exacerbation of acute pulmonary edema during assisted mechanical ventilation using a low-tidal volume, lung-protective ventilator strategy. Chest 1999;116(6):1826-32.
19. Atkins PM, Mion LC, Mendelson W, et al. Characteristics and outcomes of patients who self-extubate from ventilatory support: a case-control study. Chest 1997;112(5):1317-23.
20. Schelling G, Stoll C, Haller M, et al. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 1998;26(4):651-9.
21. Simini B. Patients' perceptions of intensive care. Lancet 1999;354(9178):571-2.
22. Scragg P, Jones A, Fauvel N. Psychological problems following 1CU treatment. Anaesthesia 2001;56(1): 9-14.
23. Jones C, Griffiths RD, Humphris G, et al. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med 2001;29(3):573-80.
24. Nelson BJ, Weinert CR, Bury CL, et al. Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Crit Care Med 2000;28(11): 3626-30.
25. Rotondi AJ, Chelluri L, Sirio C, et al. Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med 2002;30(4):746-52.
26. Siegel MD, Matthay MA. Sedatives, analgesics, and paralytic agents in the intensive care unit. In: Bone RC, Dantzker DR, George RB, et al, editors. Pulmonary and critical care medicine, vol 3. St. Louis (MO): Mosby; 1997. p. 1-15.
27. Izurieta R, Rabatin JT. Sedation during mechanical ventilation: a systematic review. Crit Care Med 2002;30(12):2644-8.
28. Wong HL, Lopez-Nahas V, Molassiotis A. Effects of music therapy on anxiety in ventilator-dependent patients. Heart Lung 2001;30(5):376-87.
29. Treggiari-Venzi MM, Suter PM, de Tonnac N, et al. Successful use of hypnosis as an adjunctive therapy for weaning from mechanical ventilation. Anesthesiology 2000;92(3):890-2.
30. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001;29(2): 277-82.
31. Puntillo KA, Stannard D, Miaskowski C, et al. Use of a pain assessment and intervention notation (P.A.I.N.) tool in critical care nursing practice: nurses' evaluations. Heart Lung 2002;31(4):303-14.
32. Payen JF, Bru O, Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001;29(12):2258-63.
33. Murray MJ, DeRuyter ML, Harrison BA. Opioids and benzodiazepines. Crit Care Clin 1995;11:849-73.
34. Mazzeo AJ. Sedation for the mechanically ventilated patient. Crit Care Clin 1995;11:937-55.
35. Osborne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br Med J (Clin Res Ed) 1986;292(6535): 1548-9.
36. Bosscha K, Nieuwenhuijs VB, Vos A, et al. Gastrointestinal motility and gastric tube feeding in mechanically ventilated patients. Crit Care Med 1998;26(9): 1510-7.
37. Viscomi CM, Bailey PL. Opioid-induced rigidity after intravenous fentanyl. Obstet Gynecol 1997;89(5 Pt 2): 822-4.
38. Barr J, Donner A. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin 1995;11:827-47.
39. Chamorro C, de Latorre FJ, Montero A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med 1996;24:932-9.
40. Greenblatt DJ, von Moltke LL, Ehrenberg BL, et al. Kinetics and dynamics of lorazepam during and after continuous intravenous infusion. Crit Care Med 2000;28(8):2750-7.
41. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26(5): 947-56.
42. Young C, Knudsen N, Hilton A, et al. Sedation in the intensive care unit. Crit Care Med 2000;28(3): 854-66.
43. Bodenham A, Park GR. Reversal of prolonged sedation using flumazenil in critically ill patients. Anaesthesia 1989;44:603-5.
44. Prielipp RC, Coursin DB, Wood KE, et al. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Crit Care Clin 1995;11:983-1003.
45. Malacrida R, Fritz ME, Suter PM, et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992;20:1123-6.
46. Shafer A, Doze VA, White PF. Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med 1990;18:1039-41.
47. Ahonen J, Olkkola KT, Takala A, et al. Interaction between fluconazole and midazolam in intensive care patients. Acta Anaesthesiol Scand 1999;43(5): 509-14.
48. Swart EL, van Schijndel RJ, van Loenen AC, et al. Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 1999;27(8):1461-5.
49. Cemaianu AC, DelRossi AJ, Flum DR, et al. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med 1996;24:222-8.
50. McCollam JS, O'Neil MG, Norcross ED, et al. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999;27(11):2454-8.
51. Tuohy KA, Nicholson WJ, Schiffman F. Agitation by sedation. Lancet 2003;361(9354):308.
52. Reynolds HN, Teiken P, Regan ME, et al. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion. Crit Care Med 2000;28(5):1631-4.
53. Tayar J, Jabbour G, Saggi SJ. Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med 2002;346(16):1253-4.
54. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994;22:1241-7.
55. Barr J, Zomorodi K, Bertaccini EJ, et al. A double-blind, randomized comparison of IV lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001;95(2): 286-98.
56. Cammarano WB, Pittet JF, Weitz S, et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998;26(4): 676-84.
57. Lund N, Papadakos PJ. Barbiturates, neuroleptics, and propofol for sedation. Crit Care Clin 1995;11:875-86.
58. Mirenda J, Broyles G. Propofol as used for sedation in the ICU. Chest 1995;108:539-48.
59. Beller JP, Pottecher T, Lugnier A, et al. Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth 1988;61:583-8.
60. Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95(2):324-33.
61. Hall RI, Sandham D, Cardinal P, et al. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001;119(4):1151-9.
62. Albanese J, Martin C, Lacarelle B, et al. Pharmacokinetics of long-term propofol infusion for sedation in ICU patients. Anesthesiology 1990;73:214-7.
63. Kress JP, O'Connor MF, Pohlman AS, et al. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am J Respir Crit Care Med 1996;153:1084-8.
64. Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, et al. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997;25(1):33-40.
65. McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med 2000;28(6):1781-4.
66. Weinbroum AA, Halpern P, Rudick V, et al. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997;23(12):1258-63.
67. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, et al. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001;29(2):317-22.
68. Webb SA, Roberts B, Breheny FX, et al. Contamination of propofol infusions in the intensive care unit: incidence and clinical significance. Anaesth Intensive Care 1998;26(2):162-4.
69. Weber RJ, Kane SL, Oriolo VA, et al. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing 1CU pharmacotherapy. Crit Care Med 2003;31(1 Suppl S):S17-24.
70. Carrasco G, Cabre L, Sobrepere G, et al. Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med 1998;26(5):844-51.
71. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286(21): 2703-10.
72. McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc 2003;51:591-8.
73. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001;27(12):1892-900.
74. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001;29(7):1370-9.
75. Stern TA. Continuous infusion of haloperidol in agitated, critically ill patients. Crit Care Med 1994;22:378-9.
76. Riker RR, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994;22(3):433-40.
77. Sharma ND, Rosman HS, Padhi ID, et al. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81(2): 238-40.
78. O'Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother 1999;33(10):1046-50.
79. Cammarano WB, Drasner K, Katz JA. Pain control, sedation, and use of muscle relaxants. In: Hall JB, Schmidt GA, Wood LDH, editors. Principles of critical care. 2nd edition. New York: McGraw-Hill; 1998. p. 87-109.
80. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59(2):263-8 [discussion 269-70].
81. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54(12):1136-42.
82. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90(3): 699-705.
83. Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2(920):656-9.
84. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27(7):1325-9.
85. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166(10):1338-44.
86. Devlin JW, Boleski G, Mlynarek M, et al. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 1999;27(7):1271-5.
87. de Lemos J, Tweeddale M, Chittock D. Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction an Calmness Scale. J Clin Epidemiol 2000;53(9):908-19.
88. Detriche O, Berre J, Massaut J, et al. The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth 1999;83(5):698-701.
89. Simmons LE, Riker RR, Prato BS, et al. Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. Crit Care Med 1999;27(8): 1499-504.
90. Hansen-Flaschen J, Cowen J, Palomano RC. Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med 1994;22:732-3.
91. Riker RR, Fraser GL, Simmons LE, et al. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med 2001;27(5): 853-8.
92. Rundshagen I, Schnabel K, Pothmann W, et al. Cortical arousal in critically ill patients: an evoked response study. Intensive Care Med 2000;26(9):1312-8.
93. Schulte-Tamburen AM, Scheier J, Briegel J, et al. Comparison of five sedation scoring systems by means of auditory evoked potentials. Intensive Care Med 1999;25(4):377-82.
94. Iselin-Chaves IA, El Moalem HE, Gan TJ, et al. Changes in the auditory evoked potentials and the bispectral index following propofol or propofol and alfentanil. Anesthesiology 2000;92(5):1300-10.
95. Riker RR, Fraser GL. Neuromuscular blockade, and delirium in adult ICU patients. Sem Resp Crit Care Med 2001;22:189-98.
96. Glass PS, Bloom M, Kearse L, et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997;86(4):836-47.
97. Liu J, Singh H, White PF. Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 1996;84:64-9.
98. Shapiro BA. Bispectral index: better information for sedation in the intensive care unit? Crit Care Med 1999;27(8):1663-4.
99. Nasraway Jr SS, Wu EC, Kelleher RM, et al. How reliable is the Bispectral Index in critically ill patients? A prospective, comparative, single-blinded observer study. Crit Care Med 2002;30(7):1483-7.
100. Gill M, Green SM, Krauss B. A study of the bispectral index monitor during procedural sedation and analgesia in the emergency department. Ann Emerg Med 2003;41(2):234-41.
101. Frenzel D, Greim CA, Sommer C, et al. Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients? Intensive Care Med 2002;28(2):178-83.
102. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999;27(12):2609-15.
103. Saito M, Terao Y, Fukusaki M, et al. Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth Analg 2003;96(3):834-8.
104. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30(1):142-56.
105. Douglass JA, Tuxen DV, Horne M, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-9.
106. Lynn J, Teno JM, Phillips RS, et al. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med 1997;126:97-106.
107. Anonymous. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators [see comments]. [published erratum appears in JAMA 1996;275(16):1232] JAMA 1995;274(20):1591-8.
108. Anonymous. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators [see comments]. [published erratum appears in JAMA 1996;275(16):1232] JAMA 1995;274(20):1591-8.
109. Hall RI, Rocker GM. End-of-life care in the ICU. Treatments provided when life support was or was not withdrawn. Chest 2000;118:1424-30.
110. Campbell ML, Bizek KS, Thill M. Patient responses during rapid terminal weaning from mechanical ventilation. A prospective study. Crit Care Med 1999;27:73-7.